Latest chronic pain Stories
FAIRFIELD, Conn., Aug.
COLUMBUS, Ohio, Aug.
FREDERICK, Md., Aug.
LIberate420 to focus on non-narcotic therapies; Dr.
PAINWeek, the National Conference on Pain for Frontline Practitioners, announced today that the American Pain Society (APS) will return to the conference for the 3rd consecutive year to contribute
Liberate420 to Focus on Non-narcotic Therapies; Dr.
When researchers at Canada’s McGill University wanted to study the genetic factors affecting chronic pain, they turned to Open Health Network to help.
ReportsnReports.com adds “Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 202” to its store. Dallas, TX (PRWEB) July 20, 2014 Neuropathic
ADYX-003, Randomized, Placebo-Controlled Study to Evaluate Safety and Efficacy of Two Dose-Volume Levels of AYX1 for the Prevention of Pain Following Total Knee Replacement SAN FRANCISCO,
FDA also approves the use of two Butrans patches for dose adjustments in appropriate chronic pain patients STAMFORD, Conn., July 16, 2014 /PRNewswire/ -- Purdue Pharma L.P.
- An armed gangster.